Filing Details

Accession Number:
0001181431-13-019219
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-27 20:07:21
Reporting Period:
2013-03-25
Filing Date:
2013-03-27
Accepted Time:
2013-03-27 20:07:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1373707 Tetraphase Pharmaceuticals Inc TTPH Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1296771 Gordon John Freund 525 University Ave., Ste 610
Palo Alto CA 94301
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-03-25 72,069 $0.00 82,414 No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P
Common Stock Acquisiton 2013-03-25 94,003 $0.00 176,417 No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
Common Stock Acquisiton 2013-03-25 393,864 $0.00 570,281 No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
Common Stock Acquisiton 2013-03-25 938,853 $0.00 1,509,134 No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
Common Stock Acquisiton 2013-03-25 681,012 $7.00 2,190,146 No 4 P Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P
No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
No 4 C Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
No 4 P Indirect By Skyline Venture Partners Qualified Purchaser IV L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Convertible Participating Preferred Stock Disposition 2013-03-25 2,090,000 $0.00 72,069 $0.00
Common Stock Series A-2 Convertible Participating Preferred Stock Disposition 2013-03-25 2,726,086 $0.00 94,003 $0.00
Common Stock Series B Convertible Participating Preferred Stock Disposition 2013-03-25 11,422,045 $0.00 393,864 $0.00
Common Stock Series C Convertible Participating Preferred Stock Disposition 2013-03-25 27,226,760 $0.00 938,853 $0.00
Common Stock Non-qualified stock option (right to buy) Acquisiton 2013-03-25 20,000 $0.00 20,000 $7.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
20,000 2023-03-24 No 4 A Direct
Footnotes
  1. The Series A-1. Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the Issuer's initial public offering without payment of consideration.
  2. Held by Skyline Venture Partners Qualified Purchaser IV L.P. Skyline Venture Management IV, LLC is the General Partner of Skyline Venture Partners Qualified Purchaser IV L.P. John Freund is a Managing Director of Skyline Venture Management IV, LLC. Mr. Freund may be deemed to share voting and dispositive power with respect to all shares held by Skyline Venture Partners Qualified Purchaser IV L.P. Mr. Freund disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
  3. Not applicable.
  4. Vests in equal quarterly installments over a three-year period measured from the date of grant.